UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income	$ 66,889	$ 55,037
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	7,057	3,000
Depreciation and amortization	1,833	1,849
Net amortization of securities premiums and discounts	11	341
Increase in cash surrender value of BOLI	(1,462)	(1,668)
Gain on BOLI death benefit	(4,346)	0
(Increase)/decrease in deferred income taxes, net	(1,994)	2,356
Loss on sale of securities available-for-sale	5,686	2,985
Net changes in:
Other assets	2,368	(2,362)
Other liabilities	18,297	18,134
Net cash provided by operating activities	94,339	79,672
Cash flows from investing activities:
Net change in loans and leases held-for-investment	(59,022)	(86,401)
Purchase of available-for-sale securities	(4,515)	(10,135)
Purchase of held-to-maturity securities	(3,814)	(168,634)
Proceeds from sales, maturities, calls and pay downs of available-for-sale securities	46,751	62,979
Proceeds from maturities, calls and pay downs of held-to-maturity securities	37,524	52,884
Purchase of premises and equipment	(4,493)	(3,318)
Purchase of other investments	(5,263)	(5,300)
Proceeds from bank-owned life insurance	11,752	513
Proceeds from sale of assets	27	73
Net cash provided by (used in) investing activities	18,947	(157,339)
Cash flows from financing activities:
Net (decrease) increase in deposits	(10,502)	269,105
Cash dividends paid	(6,286)	(6,110)
Net cash used in share repurchase of common stock	(16,394)	(17,905)
Net cash (used in) provided by financing activities	(33,182)	245,090
Net change in cash and cash equivalents	80,104	167,423
Cash and cash equivalents, beginning of period	588,257	715,460
Cash and cash equivalents, end of period	668,361	882,883
Supplemental disclosures of cash flow information:
Cash paid for interest	18,664	3,832
Income taxes paid	16	11,451
Supplemental disclosures of non-cash transactions:
Net change in unrealized gain/(losses) on securities available-for-sale	$ 1,676	$ (36,692)